🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This research project is designed to promote health among first-year colleg...
Status
Completed
Location
University of Minnesota
Start Date
2019-07-31
Trial ID
NCT03930524
This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-10-25
Trial ID
NCT07420959
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested
Late 2013, the first indigenous cases of chikungunya have been observed in ...
Status
Completed
Location
CHU de Guadeloupe
Start Date
2015-02
Trial ID
NCT02553369
Treatments Being Tested
Although saliva is not generally regarded as one of the most interesting bi...
Status
Terminated
Location
CHRU
Start Date
2012-06-21
Trial ID
NCT02864303
Treatments Being Tested
BICHE- 1: Brain Irradiation for Childhood cancer - Endocrine monitoring dur...
Status
Recruiting
Location
CHU Angers
Start Date
2025-10-10
Trial ID
NCT06618703
Treatments Being Tested
This study evaluates the effects of a video game embedded in a commercially...
Status
Completed
Location
University of California San Francisco
Start Date
2022-02-09
Trial ID
NCT05227027
Treatments Being Tested
Age-Related Macular Degeneration (ARMD) is the most common cause of blindne...
Status
Completed
Location
CHU Brugmann
Start Date
2013-08-01
Trial ID
NCT02762188
Treatments Being Tested